Cite
HARVARD Citation
Rambaldi, A. et al. (2020). Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemia. Cancer. 126 (2), pp. 304-310. [Online].